Navigation Links
European Drug Delivery Technologies Market to Reach $59.1 Billion By 2017 - New Report by MarketsandMarkets

(PRWEB) June 06, 2013

The "European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017", analyzes and studies the major market drivers, restraints and opportunities in the following regions:

  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Russia
  • Rest of Europe (RoE)


  • 140 Market Data Tables
  • 20 Figures
  • 300 Pages and an in-depth Table of Content on “European Drug Delivery Technologies Market"

Early buyers will receive 10% customization on this report.

The European drug delivery market was worth $39.9 billion in the year 2012. This market is expected to grow at a healthy rate over the next five-year period owing to the rising incidences of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing demand for self administration and home healthcare devices, patent expires of certain blockbuster drugs and growing focus on pediatric and geriatric patients.

The European Drug Delivery Market is categorized into Nine Segments:

  • Oral
  • Pulmonary
  • Transdermal
  • Injectable
  • Ocular
  • Nasal
  • Topical
  • Implantable
  • Transmucosal

Oral Drug Delivery occupied the largest market share in Europe in 2012, while pulmonary drug delivery is the fastest growing segment of the European drug delivery market.

Prefilled and fillable syringes, metered dose inhalers, transdermal patches, needle-free injectors, auto and pen injectors are some of the commonly adopted drug delivery technologies in Europe. The use of implantable devices like cardiac stents and brachytherapy seeds for drug delivery is also increasing in adoption rates.

Strategic collaborations in the industry, home care drug delivery devices and expanding applications of drug delivery into niche therapeutic areas present tremendous opportunities for the growth of this market. With the increasing geriatric population of Europe, the demand for home care drug delivery devices is also increasing.

Germany is the largest market for drug delivery, followed by France and the U.K.These three countries have a well-established pharmaceutical industry, which has stimulated the growth of the drug delivery market in these regions. The Russian and RoE market share expected to witness double digit growth over the next five years, owing to the growing investments in the pharmaceutical industry and the development of healthcare infrastructure.

Key players in the European drug delivery Technologies Market are Becton, Dickinson & Company (U.S.), Novartis (Switzerland), AstraZeneca (U.K.), Skye Pharma PLC (U.K.), Johnson & Johnson (U.S), Ypsomed Holding AG (Switzerland), GlaxoSmithKline (U.K.), 3M Company (U.S.), and Alkermes (Ireland). Some of the emerging companies in this field include Drug Delivery International (U.K.), Foamix (Israel), QLT (Canada), and Bend Research (U.S.).

Buy a copy of this report @

Find related Reports to - Biotechnology Market

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales(at)marketsandmarkets(dot)com
Connect with us on LinkedIn
Connect with us on Facebook

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. CDISC Proudly Announces the Registration of a Branch Office of the CDISC European Foundation in Hong Kong
2. AxoGen, Inc. Announces Presentation of Avance® Nerve Graft Data at the 18th Federation of European Societies for Surgery of the Hand Congress
3. A pan-European study: Signs of motor disorders can appear years before disease manifestation
4. Phoseon Technology Presents the Leading UV LED Curing Solutions at IMI European Ink Jet Conference
5. Media registration for the European Cancer Congress
6. AfriCoLeish receives funding boost from European Union
7. The Body By Vi 90 Day Challenge Is Predicted to be The #1 Weight Loss and Fitness Platform in the UK as ViSalus Launches in the European Market
8. American Drivers Phone, Text More Often Than European Motorists
9. Covers 2013 European Congress of Radiology
10. Research & Markets Announces the Release of 'European Road Freight Transport 2012'
11. More Danish women are physically active than their European neighbors, but remain indifferent to sport
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA Training ... Institute Education Center headquartered in Northern California, has issued an important reminder to ... their worksites. Employers with workers exposed to high temperatures should establish a ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of ... has announced the formation of a new biotechnology company, Noxopharm Limited ... $6m in an IPO and to list on the ASX. ... candidate, NOX66, ready to enter a Phase 1 clinical study later ... designed to address one of the biggest problems facing cancer patients ...
(Date:6/26/2016)... DUBLIN , June 27, 2016 Jazz ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... proposed acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... 11:59 p.m. (Eastern Daylight Time). As previously ... entered into a definitive merger agreement under which Jazz ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: